JamesTaylorVIMD
Hematology • Washington, DCSickle Cell & Other Anemias
Director, Center for Sickle Cell Disease, Howard University ; Professor of Medicine and Microbiology, Howard University College of Medicine
Dr. Taylor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2041 Georgia Ave NW
Washington, DC 20060Phone+1 612-625-1110Fax+1 202-865-5018- Is this information wrong?
Summary
- Dr. James Taylor specializes in Hematology in Washington, DC and is affiliated with Howard University Hospital. Since 2017, he has served as the Director of the Howard University Center for Sickle Cell Disease. He is a Professor of Medicine (Hematology/Oncology) and Microbiology at Howard University College of Medicine; and also an Adjunct Professor in Food and Nutrition Sciences at the University of Manitoba, Winnipeg, Canada. He received his medical degree from Medical College of Wisconsin and has been in practice 22 years. He specializes in sickle cell & other anemias and is experienced in pulmonary hypertension, sickle-cell anemia, general internal medicine, clinical research, and genetic analysis. He is also a faculty member for training MS and PhD students.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1998 - 2001
Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1995 - 1998
Medical College of WisconsinClass of 1995
Certifications & Licensure
MD State Medical License 2001 - 2025
DC State Medical License 2016 - 2024
MO State Medical License 1997 - 2022
MN State Medical License 2016 - 2018- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- John Benjamin Nichols Award Medical Society of the District of Columbia, 2023
- Humanitarian Award Queens Sickle Cell Action Network (QSCAN)/SCDAA, 2019
Clinical Trials
- Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia Start of enrollment: 2008 Feb 19
- Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria Start of enrollment: 2006 Jun 15
- Genetics and Pain Severity in Sickle Cell Disease Start of enrollment: 2012 Jun 17
- Join now to see all
Publications & Presentations
PubMed
- Antiviral response and HIV-1 inhibition in sickle cell disease.Taylor, J., Namita Kumari, Asrar Ahmad, Clemilson Berto-Junior, Andrey Ivanov, Fayuan Wen, Xionghao Lin, Sharmin Diaz, Iheanyi Okpala, James G Taylor, Marina Jerebtsov...> ;Iscience. 2024 Feb 16
- 1 citationsSingle nucleotide polymorphisms incoding regions in sickle cell disease and their potential miRNA binding sites.Chutima Kumkhaek, Christine Kim, Gulriz Kurban, Jianqiong Zhu, Wulin Aerbajinai, Taylor, J., Taylor, J., James G Taylor, Griffin P Rodgers> ;Ejhaem. 2022 Nov 1
- 1 citationsSoluble urokinase-type plasminogen activator receptor in sickle cell disease-associated chronic kidney disease.Nowah Afangbedji, Namita Kumari, Sharmin Diaz, Fayuan Wen, James G Taylor, Sergei Nekhai, Marina Jerebtsova> ;Blood Advances. 2023 May 9
- Join now to see all
Press Mentions
Hematologists consider where new therapies fit in sickle cell treatment paradigmDecember 19th, 2023
Top DC doctor reacts to new sickle cell treatmentDecember 15th, 2023
U.S. FDA approves 2 sickle cell gene therapies in medical breakthroughDecember 10th, 2023- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
Other Languages
- French
Hospital Affiliations
Howard University HospitalWashington, District of Columbia
External Links
- ORCIDhttps://orcid.org/0000-0002-4421-1809
- Scopus profilehttps://www.scopus.com/authid/detail.uri?authorId=7405408594
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
